Literature DB >> 26617740

Overexpression of histone demethylase JMJD5 promotes metastasis and indicates a poor prognosis in breast cancer.

Zhihua Zhao1, Chuntao Sun2, Fengqi Li3, Jiankui Han4, Xanjun Li3, Zhenguo Song3.   

Abstract

In this study, we showed the expression of JMJD5 was increased in breast cancer tissues and breast adenocarcinoma cell lines MCF-7 as well as triple negative breast cancer cell lines MDA-MB-231 compared with paired adjacent normal mammary tissues and normal mammary epithelial cell lines MCF-10A. The higher expression of JMJD5 was significantly corresponded with clinical stage, histological grade and lymph node metastasis. Overexpression of JMJD5 promoted cell invasion and induce EMT, while JMJD5 siRNA inhibits MDA-MB-231 cells invasion in vitro. Moreover, qChIP analysis revealed the Snail family proteins Snai1 was the direct target of JMJD5 in breast cancer cells. Luciferase reporter assays suggested that the overexpression of JMJD5 resulted in the activation of Snail1 promoter-driven luciferase reporter. The changes in the level of RNA and protein implied that the activation of Snail was the important mechanisms by which JMJD5 triggers metastasis. We also detected the higher expression of JMJD5 protein was an independent unfavorable biomarker for worse overall survival in breast cancer patients. Therefore, our results identified an important role for JMJD5 in breast cancer through the regulation of snail1.

Entities:  

Keywords:  JMJD5; biomarker; breast cancer; metastasis; snail

Mesh:

Substances:

Year:  2015        PMID: 26617740      PMCID: PMC4637555     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

1.  KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation.

Authors:  Datsun A Hsia; Clifford G Tepper; Mamata R Pochampalli; Elaine Y C Hsia; Chie Izumiya; Steve B Huerta; Michael E Wright; Hong-Wu Chen; Hsing-Jien Kung; Yoshihiro Izumiya
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  DLP, a novel Dim1 family protein implicated in pre-mRNA splicing and cell cycle progression.

Authors:  Xiaojing Sun; Hua Zhang; Dan Wang; Dalong Ma; Yan Shen; Yongfeng Shang
Journal:  J Biol Chem       Date:  2004-05-25       Impact factor: 5.157

Review 3.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

Review 4.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

5.  Jmjd5, an H3K36me2 histone demethylase, modulates embryonic cell proliferation through the regulation of Cdkn1a expression.

Authors:  Akihiko Ishimura; Ken-ichi Minehata; Minoru Terashima; Gen Kondoh; Takahiko Hara; Takeshi Suzuki
Journal:  Development       Date:  2012-01-12       Impact factor: 6.868

6.  Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

Authors:  Y Shang; X Hu; J DiRenzo; M A Lazar; M Brown
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

7.  Coordinated regulation of AIB1 transcriptional activity by sumoylation and phosphorylation.

Authors:  Huijian Wu; Luyang Sun; Ying Zhang; Yupeng Chen; Bin Shi; Ruifang Li; Yan Wang; Jing Liang; Dongwei Fan; Ge Wu; Dan Wang; Shaosi Li; Yongfeng Shang
Journal:  J Biol Chem       Date:  2006-06-07       Impact factor: 5.157

8.  Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis.

Authors:  Huijian Wu; Yupeng Chen; Jing Liang; Bin Shi; Ge Wu; Ying Zhang; Dan Wang; Ruifang Li; Xia Yi; Hua Zhang; Luyang Sun; Yongfeng Shang
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

9.  Conserved antagonism between JMJD2A/KDM4A and HP1γ during cell cycle progression.

Authors:  Joshua C Black; Andrew Allen; Capucine Van Rechem; Emily Forbes; Michelle Longworth; Katrin Tschöp; Claire Rinehart; Jonathan Quiton; Ryan Walsh; Andrea Smallwood; Nicholas J Dyson; Johnathan R Whetstine
Journal:  Mol Cell       Date:  2010-12-10       Impact factor: 17.970

10.  The Saccharomyces cerevisiae histone demethylase Jhd1 fine-tunes the distribution of H3K36me2.

Authors:  Jia Fang; Gregory J Hogan; Gaoyang Liang; Jason D Lieb; Yi Zhang
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

View more
  15 in total

Review 1.  The small members of the JMJD protein family: Enzymatic jewels or jinxes?

Authors:  Sangphil Oh; Sook Shin; Ralf Janknecht
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-26       Impact factor: 10.680

Review 2.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

3.  Clipping of arginine-methylated histone tails by JMJD5 and JMJD7.

Authors:  Haolin Liu; Chao Wang; Schuyler Lee; Yu Deng; Matthew Wither; Sangphil Oh; Fangkun Ning; Carissa Dege; Qianqian Zhang; Xinjian Liu; Aaron M Johnson; Jianye Zang; Zhongzhou Chen; Ralf Janknecht; Kirk Hansen; Philippa Marrack; Chuan-Yuan Li; John W Kappler; James Hagman; Gongyi Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-28       Impact factor: 11.205

Review 4.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

5.  Miz1 Controls Schwann Cell Proliferation via H3K36me2 Demethylase Kdm8 to Prevent Peripheral Nerve Demyelination.

Authors:  David Fuhrmann; Marco Mernberger; Andrea Nist; Thorsten Stiewe; Hans-Peter Elsässer
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

6.  Depletion of JMJD5 sensitizes tumor cells to microtubule-destabilizing agents by altering microtubule stability.

Authors:  Junyu Wu; Zhimin He; Da-Liang Wang; Fang-Lin Sun
Journal:  Cell Cycle       Date:  2016-10-07       Impact factor: 4.534

7.  KDM4C Activity Modulates Cell Proliferation and Chromosome Segregation in Triple-Negative Breast Cancer.

Authors:  Jeison Garcia; Fernando Lizcano
Journal:  Breast Cancer (Auckl)       Date:  2016-11-02

8.  JMJD5 is a human arginyl C-3 hydroxylase.

Authors:  Sarah E Wilkins; Md Saiful Islam; Joan M Gannon; Suzana Markolovic; Richard J Hopkinson; Wei Ge; Christopher J Schofield; Rasheduzzaman Chowdhury
Journal:  Nat Commun       Date:  2018-03-21       Impact factor: 14.919

9.  Genome-scale identification of microRNA-related SNPs associated with risk of head and neck squamous cell carcinoma.

Authors:  Owen M Wilkins; Alexander J Titus; Jiang Gui; Melissa Eliot; Rondi A Butler; Erich M Sturgis; Guojun Li; Karl T Kelsey; Brock C Christensen
Journal:  Carcinogenesis       Date:  2017-10-01       Impact factor: 4.944

10.  Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance.

Authors:  Wai Hoong Chang; Donall Forde; Alvina G Lai
Journal:  Cancer Commun (Lond)       Date:  2019-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.